Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Journal of Public Health (Oxford, England)|March 15, 2018
Learning from games: stakeholders' experiences involved in local health policyH P E M Spitters, L A M van de Goor, C Juel Lau, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin BJ T Guptill, S M Raja, V C Juel, et al.
Annals of Neurology|September 6, 2025
A Distinct Immunological Signature in Late-Onset Myasthenia Gravis: Insights from an Exploratory Proteomics StudyBhaskar Roy, Jiaxin Chen, Fatemeh Khani-Habibabadi, et al.
Annals of Clinical and Translational Neurology|March 16, 2023
Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravisGianvito Masi, Minh C Pham, Tabitha Karatz, et al.
Experimental Neurology|November 26, 2018
Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patientsYingkai Li, Jeffrey T Guptill, Melissa A Russo, et al.
Autoimmunity|September 30, 2016
Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravisJeffrey T Guptill, Vern C Juel, Janice M Massey, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2015
Characterization of B cells in muscle-specific kinase antibody myasthenia gravisJeffrey T Guptill, John S Yi, Donald B Sanders, et al.
Journal of Neuroimmunology|June 5, 2020
Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravisYingkai Li, Jeffrey T Guptill, Melissa A Russo, et al.
Pageof 12